# Envoy Medical, Inc. Class A Common Stock (COCH)

> Envoy Medical, Inc. Class A Common Stock (COCH) trades at $6.74 (-1.10%) as of 7:30:01 PM EST on Nov 13, 2026, +4.47% over the past month. Market cap is $52.16M, with 2.7 days to cover in short interest.

Canonical: https://massive.com/quote/coch
Data as of: 2026-11-14T00:30:01.931Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$6.74** -0.07 (-1.10%)
As of 7:30:01 PM EST on Nov 13, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Envoy Medical, Inc. Class A Common Stock (COCH) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -1.10% |
| 1W | -5.80% |
| 1M | +4.47% |
| YTD | +1.88% |
| 1Y | +3.28% |
| 52-wk range | $3.63 – $9.54 |

From daily closes through Nov 13, 2026.

## Key statistics

Today's trading snapshot for COCH: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $6.50 – $6.92 |
| Open | $6.60 |
| Prev close | $6.81 |
| Volume | 10.03K |
| Market cap | $52.16M |
| Shares out | 7.74M |

## Valuation and profitability ratios

Valuation and profitability ratios for Envoy Medical, Inc. Class A Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 225.96 |
| P/B | -34.09 |
| P/FCF | — |
| ROE | 1695.0% |
| ROA | -135.5% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 13, 2026

## Insider trading

[Envoy Medical, Inc. Class A Common Stock (COCH) insider trading](https://massive.com/quote/coch/insider-trading.md): open-market Form 4 buys and sells by Envoy Medical, Inc. Class A Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Envoy Medical, Inc. Class A Common Stock has disclosed to the SEC on Form 8-K.

- Nov 5, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 5, 2026, Envoy Medical, Inc. (the "Company"), issued a press release regarding the Company's financial results for its fiscal quarter ended September 30, 2026.”
- Oct 27, 2026 · Charter amendment
  “On October 23, 2026, Envoy Medical, Inc. ... filed a certificate of amendment to the Company's Second Amended and Restated Certificate of Incorporation ... to effectuate a 1-for-10 reverse stock split.”
- Oct 16, 2026 · Charter amendment
  “"the Company's stockholders... voted to approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to, at the discretion of the Board of Directors, effect one or more reverse stock splits with respect to our issued and outstanding Class A Common Stock... at a ratio of 1-for-5 to 1-for-25"”
- Oct 7, 2026 · Settlement agreement
  “On October 6, 2026, Envoy Medical, Inc. entered into a Dismissal Agreement regarding litigation in the Delaware Court of Chancery (the "Litigation") with Atlas Merchant Capital SPAC Fund I LP. Pursuant to the terms of the Dismissal Agreement, all of Atlas' claims will be dismissed with prejudice, and there will be no further proceedings in relation to the Litigation; neither the Company nor any other defendant will be required to make a payment to Atlas under the Dismissal Agreement.”
- Aug 27, 2026 · Executive compensation change
  “Pursuant to the terms of the Employment Agreement, Mr. Potashnick is entitled to a base salary of $315,000 per year, an initial target bonus equal to 15% of his base salary payable upon the Company's achievement of certain performance goals, and an initial equity award of 250,000 stock options at an exercise price of $0.746 per share, the closing price of the Company's Class A Common Stock on the hire date. The Employment Agreement also provides for six months of severance compensation in connection with certain terminations of Mr. Potashnick's employment.”

## Dividend history and stock splits

Envoy Medical, Inc. Class A Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-10 · Oct 26, 2026

## Similar companies

Public companies in a similar business to Envoy Medical, Inc. Class A Common Stock.

- [VANI](https://massive.com/quote/vani.md) Vivani Medical, Inc. Common Stock (DE) (+2.71%)

Daily change in the latest session, 15-minute delayed.

## COCH short interest

How heavily COCH is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 2.7 |
| Short interest | 89.92K |
| Avg volume | 33.64K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## COCH news

The latest news and headlines about Envoy Medical, Inc. Class A Common Stock (COCH).

- [Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates](https://www.zacks.com/stock/news/3023619/sight-sciences-inc-sght-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3023619) · Zacks Investment Research · Nov 4, 2026 · neutral sentiment
- [EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies](https://www.globenewswire.com/news-release/2025/04/22/3065284/11768/en/EdgarAgents-Debuts-EA34-Plugin-at-Centri-Capital-Conference-to-Simplify-and-Expedite-Financial-Filing-Process-for-Mid-to-Microcap-Companies.html) · GlobeNewswire Inc. · Apr 22, 2025 · neutral sentiment
- [Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device](https://www.globenewswire.com/news-release/2024/11/01/2973312/0/en/Envoy-Medical-Receives-FDA-Approval-To-Initiate-Pivotal-Clinical-Study-for-Breakthrough-Hearing-Device.html) · GlobeNewswire Inc. · Nov 1, 2024 · positive sentiment
- [Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index](https://www.globenewswire.com/news-release/2024/06/06/2894690/0/en/Envoy-Medical-Announces-Inclusion-in-the-MSCI-USA-Micro-Cap-Index.html) · GlobeNewswire Inc. · Jun 6, 2024
- [Envoy Medical Reports First Quarter 2024 Results](https://www.globenewswire.com/news-release/2024/05/15/2882892/0/en/Envoy-Medical-Reports-First-Quarter-2024-Results.html) · GlobeNewswire Inc. · May 15, 2024

## About Envoy Medical, Inc. Class A Common Stock

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 47 |
| Listed | Oct 2, 2023 |

[Company website](https://www.envoymedical.com)

## FAQ

### What is the Envoy Medical, Inc. Class A Common Stock (COCH) stock price today?

Envoy Medical, Inc. Class A Common Stock (COCH) is trading at $6.74 (-1.10% on the day) as of 7:30:01 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Envoy Medical, Inc. Class A Common Stock?

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is…

### What is the short interest in COCH?

As of Oct 30, 2026, COCH has 89.92K shares short and 2.7 days to cover.

### What exchange is COCH listed on?

Envoy Medical, Inc. Class A Common Stock (COCH) trades on Nasdaq in USD, in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry.

## Live data

Prices here are 15-minute delayed. For real-time COCH quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=COCH`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Envoy Medical, Inc. Class A Common Stock (COCH) insider trading](https://massive.com/quote/coch/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
